The MS Society of Canada’s research team is preparing to fly over the Atlantic to the exciting city of Berlin, Germany to attend the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) from October 10-12, 2018.
With thousands of participants from all over the world attending, the conference is bound to provide the latest information on research on multiple sclerosis (MS). Topics at this year’s meeting include pediatric MS, clinical trial in MS, immunology, neurodegeneration, novel technologies and treatment monitoring, just to name a few. Selected abstracts will be presented throughout the week at poster sessions (researchers showcase their data on posters and engage in discussions) and scientific sessions (presentations that are delivered to a larger audience). The conference also includes smaller workshops and education sessions for nurses, junior neurologists in training, and media.
The conference is a great platform for announcing breaking news in MS research and treatments and provides an opportunity for researchers, clinicians, and trainees to share the hottest data from their laboratories. Stay tuned for all this information!
This year the research team will be delivering live updates throughout the meeting via Twitter(@Dr_KarenLee), Facebook (Multiple Sclerosis Society of Canada), Instagram (@mssocietycanada) and my blog. We are excited to hear about the latest advances in MS and report it to our MS Community, including, interviews on researchers that we support.
Check out the scientific program to let us know what you are interested in hearing about.